Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HCC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01666145
What this trial is testing

Advanced Image Guidance Utilized in Liver Surgery

Who this might be right for
Carcinoma, Hepatocellular
Wake Forest University Health Sciences 14
Early research (Phase 1)Study completedNCT01116804
What this trial is testing

Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)

Who this might be right for
Primary Liver Cancer
University Hospital, Ghent 36
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Large-scale testing (Phase 3)UnknownNCT02709070
What this trial is testing

Resection+Highly Purified CTL Versus Resection Alone for HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 210
Testing effectiveness (Phase 2)Looking for participantsNCT07331883
What this trial is testing

Sintilimab Combined With Bevacizumab Biosimilar as Adjuvant Treatment After Resection of Ruptured Hepatocellular Carcinoma (CLEAR-2)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Ruijin Hospital 35
Not applicableUnknownNCT06272656
What this trial is testing

Evaluation of AKR1B10 as a New Marker for Interventional Therapy of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Hebei Medical University Third Hospital 200
Not applicableStudy completedNCT02613156
What this trial is testing

Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma

Who this might be right for
Recurrent Hepatocellular Carcinoma
Sun Yat-sen University 25
Early research (Phase 1)Ended earlyNCT00828594
What this trial is testing

Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Novartis Pharmaceuticals 130
Not applicableStudy completedNCT00683631
What this trial is testing

TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Louisville 183
Early research (Phase 1)UnknownNCT05185531
What this trial is testing

Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 20
Not applicableStudy completedNCT06550739
What this trial is testing

Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Haike Lei 1,053
Large-scale testing (Phase 3)UnknownNCT04797884
What this trial is testing

Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
THERABIONIC INC. 166
Early research (Phase 1)WithdrawnNCT07365839
What this trial is testing

Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Virginia Commonwealth University
Testing effectiveness (Phase 2)UnknownNCT04165174
What this trial is testing

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

Who this might be right for
HCC
Huazhong University of Science and Technology 20
Early research (Phase 1)Study completedNCT02870010
What this trial is testing

Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 21
Not applicableLooking for participantsNCT05935189
What this trial is testing

Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens

Who this might be right for
Hepatocellular Carcinoma
Nikomed Medical Center 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Testing effectiveness (Phase 2)Looking for participantsNCT05185739
What this trial is testing

Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University College, London 60
Not applicableLooking for participantsNCT06898398
What this trial is testing

TACE Combined Surgery for the Resectable Huge HCC

Who this might be right for
Hepatocellular CarcinomaHepatic ChemotherapyLiver Cancer+1 more
Sun Yat-sen University 326
Next Page